Matrix metalloproteinases in liver and serum in chronic active hepatitis Cand HCV-induced cirrhosis

Citation
R. Lichtinghagen et al., Matrix metalloproteinases in liver and serum in chronic active hepatitis Cand HCV-induced cirrhosis, HEPATOL RES, 14(2), 1999, pp. 119-134
Citations number
44
Categorie Soggetti
Gastroenerology and Hepatology
Journal title
HEPATOLOGY RESEARCH
ISSN journal
13866346 → ACNP
Volume
14
Issue
2
Year of publication
1999
Pages
119 - 134
Database
ISI
SICI code
1386-6346(199904)14:2<119:MMILAS>2.0.ZU;2-#
Abstract
To study the value of matrix metalloproteinases as indicators of hepatic fi broproliferation, expression of MMP-1, MMP-2, MMP-7 and MMP-9 was studied i n healthy controls, patients with chronic hepatitis C (CAH) and in HCV-indu ced cirrhosis. Western blot revealed an increase for MMP-1 in CAH with hist ologically detectable fibrosis and diminished amounts in cirrhosis. MMP-2 w as unchanged in CAH and cirrhosis, while there was an increase of MMP-7 in 8 of 18 cirrhotic liver samples. Northern analysis demonstrated in cirrhosi s an increase of MMP-7 mRNA more strongly than MMP-2 mRNA. ELISA studies de monstrated a trend towards an increase in circulating MMP-2 levels and a re duction in circulating MMP-9 levels with advancing fibrosis. RT-PCR demonst rated transcripts for MMP-1, MMP-2 and MMP-7 in hepatic tissue and isolated stellate cells. MMP-9 transcripts were only found in white blood cells. He patic expression of MMP-1, MMP-2 and MMP-7 is increased in chronic hepatiti s C, but the resulting proenzyme levels are not sufficiently different to a llow discrimination between patients with and without fibroproliferation. M MP-9 shows significant changes in serum, with a progressive reduction from controls to cirrhosis, but is most likely derived from extrahepatic sources . (C) 1999 Elsevier Science Ireland Ltd. All rights reserved.